Research blendEndocrine Signaling ResearchIn stock
CJC-1295 + Ipamorelin
Also known as: CJC-1295 no-DAC 5 mg, Ipamorelin 5 mg
A research blend combining CJC-1295, Ipamorelin in one product. Each component has been studied on its own; this page links to each component's research and does not summarize studies of the combination.
Evidence: limited · Component-level research only
At a glance
Contents
CJC-1295 no-DAC 5 mg, Ipamorelin 5 mg
Format
Research blend; components studied individually
FDA status
Not FDA-approved
Research on the blend
Not summarized here; see each component below
Where it’s been studied
1PituitaryCJC-1295: GRF receptor activation, rat (2005); GH secretion, human (2006)
2Circulating hormonesCJC-1295: Pharmacokinetics measured in adults, DAC form (2006)
3BoneSkeletal measures, rat (1999)
4GutIpamorelin: Post-surgical gastric-emptying model, rat (2012)
The rat map combines the research regions of each component. It does not show studies of the blend itself.
Verified by third-party testing
CertificatePosted on the product page
TestingIndependent, third-party
Research-grade supply
PureLab supplies CJC-1295 + Ipamorelin for laboratory research. Lot-specific certificates of analysis are posted on the product page as they are issued.